Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood
暂无分享,去创建一个
K. Nathanson | K. Pajtler | J. Schiffman | G. Tomlinson | C. Kratz | M. Walsh | W. Kohlmann | J. Wasserman | L. States | Kristin Zelley | S. Rednam | H. Druker | J. Kamihara | A. Villani | A. Parareda
[1] P. Chanson,et al. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. , 2017, Endocrine-related cancer.
[2] J. Schiffman,et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. , 2016, The Lancet. Oncology.
[3] O. Dekkers,et al. Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group. , 2016, The Journal of clinical endocrinology and metabolism.
[4] Kathryn J. Rowland,et al. Management of the Parathyroid Glands During Preventive Thyroidectomy in Patients With Multiple Endocrine Neoplasia Type 2. , 2015, Annals of surgery.
[5] Douglas B. Evans,et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.
[6] G. Cevenini,et al. Reference range of serum calcitonin in pediatric population. , 2015, The Journal of clinical endocrinology and metabolism.
[7] N. Perrier,et al. CDC73-Related Disorders , 2015 .
[8] P. Vestergaard,et al. Aggressive medullary thyroid carcinoma in a ten-year-old patient with multiple endocrine neoplasia 2B due to the A883F mutation. , 2015, Thyroid.
[9] E. Laws,et al. Acromegaly: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.
[10] Jeffrey E. Lee,et al. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. , 2014, Thyroid : official journal of the American Thyroid Association.
[11] J. Varhaug,et al. Surgical Curability of Medullary Thyroid Cancer in Multiple Endocrine Neoplasia 2B: A Changing Perspective , 2014, Annals of surgery.
[12] A. Gill,et al. Negative Parafibromin Staining Predicts Malignant Behavior in Atypical Parathyroid Adenomas , 2014, Annals of Surgical Oncology.
[13] Tetsurou Yamamoto,et al. Novel tandem germline RET proto‐oncogene mutations in a patient with multiple endocrine neoplasia type 2B: Report of a case and a literature review of tandem RET mutations with in silico analysis , 2013, Head & neck.
[14] X. Hua,et al. Menin: a scaffold protein that controls gene expression and cell signaling. , 2013, Trends in biochemical sciences.
[15] N. Pellegata,et al. Multiple endocrine neoplasia syndromes associated with mutation of p27 , 2013, Journal of Endocrinological Investigation.
[16] T. Imai,et al. High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients. , 2013, European journal of endocrinology.
[17] A. Tabarin,et al. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis. , 2013, European journal of endocrinology.
[18] S. Asa,et al. Precursor lesions of endocrine system neoplasms , 2013, Pathology.
[19] C. Stratakis,et al. An update on the genetics of pheochromocytoma , 2013, Journal of Human Hypertension.
[20] P. Chanson,et al. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. , 2013, The Journal of clinical endocrinology and metabolism.
[21] J. Bilezikian,et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.
[22] M. Bots,et al. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors. , 2012, European journal of endocrinology.
[23] B. Estour,et al. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds. , 2012, Endocrine-related cancer.
[24] N. Pellegata. MENX and MEN4 , 2012, Clinics.
[25] F. Raue,et al. Genotype-phenotype correlation in multiple endocrine neoplasia type 2 , 2012, Clinics.
[26] R. Lifton,et al. Frequent Germ-Line Mutations of the MEN1, CASR, and HRPT2/CDC73 Genes in Young Patients with Clinically Non-familial Primary Hyperparathyroidism , 2012, Hormones and Cancer.
[27] G. Viglietto,et al. Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype. , 2012, European journal of endocrinology.
[28] A. Manni,et al. Familial hyperparathyroidism due to a germline mutation of the CDC73 gene: implications for management and age-appropriate testing of relatives at risk. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[29] R. Thakker,et al. Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[30] N. Pellegata,et al. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas. , 2011, The Journal of clinical endocrinology and metabolism.
[31] G. Cote,et al. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. , 2011, Thyroid : official journal of the American Thyroid Association.
[32] Martin Fassnacht,et al. Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10 , 2011, Human mutation.
[33] N. Pellegata,et al. A Novel Germline CDKN1B Mutation Causing Multiple Endocrine Tumors: Clinical, Genetic and Functional Characterization , 2010, Human mutation.
[34] M. Georgitsi,et al. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations. , 2010, Best practice & research. Clinical endocrinology & metabolism.
[35] R. Thakker,et al. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism‐jaw tumor syndrome (HPT‐JT) and parathyroid tumors , 2010, Human mutation.
[36] A. Tabarin,et al. Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients , 2010, World Journal of Surgery.
[37] G. Palù,et al. Hyperparathyroidism–jaw tumor syndrome: a report of three large kindred , 2009, Langenbeck's Archives of Surgery.
[38] H. Gharib,et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. , 2009, Thyroid : official journal of the American Thyroid Association.
[39] S. Marx,et al. Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. , 2009, The Journal of clinical endocrinology and metabolism.
[40] A. Tabarin,et al. Thymic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: A Comparative Study on 21 Cases Among a Series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines) , 2009, World Journal of Surgery.
[41] J. Bilezikian,et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. , 2009, The Journal of clinical endocrinology and metabolism.
[42] L. Barzon,et al. The extent of parathyroidectomy for HRPT2-related hyperparathyroidism. , 2009, Surgery.
[43] S. Steinberg,et al. The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism. , 2008, Surgery.
[44] G. Palù,et al. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. , 2008, Endocrine-related cancer.
[45] V. Montori,et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.
[46] D. Figarella-Branger,et al. Pituitary Tumors and Hyperplasia in Multiple Endocrine Neoplasia Type 1 Syndrome (MEN1): A Case-Control Study in a Series of 77 Patients Versus 2509 Non-MEN1 Patients , 2008, The American journal of surgical pathology.
[47] R. Thakker,et al. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene , 2008, Human mutation.
[48] Louise Izatt,et al. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. , 2007, The Journal of clinical endocrinology and metabolism.
[49] R. DeLellis,et al. Parafibromin in the Diagnosis of Parathyroid Carcinoma , 2007 .
[50] C. Larsson,et al. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. , 2007, Endocrine-related cancer.
[51] M. Tublin,et al. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. , 2007, AJR. American journal of roentgenology.
[52] C. Marcocci,et al. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? , 2007, European journal of endocrinology.
[53] H. Höfler,et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans , 2006, Proceedings of the National Academy of Sciences.
[54] A. Gill,et al. Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias , 2006, The American journal of surgical pathology.
[55] K. Owzar,et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. , 2005, The New England journal of medicine.
[56] J. Carpten,et al. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism‐jaw tumour syndrome , 2005, Journal of internal medicine.
[57] B. Teh,et al. Renal neoplasia in the hyperparathyroidism-jaw tumor syndrome. , 2004, Current molecular medicine.
[58] R. Jensen,et al. Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1. , 2004, The Journal of clinical endocrinology and metabolism.
[59] E. Mallet,et al. Reference intervals for serum calcitonin in men, women, and children. , 2004, Clinical chemistry.
[60] Ximing J. Yang,et al. Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma , 2004, Clinical Cancer Research.
[61] H. Okinaga,et al. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[62] A. Tanimoto,et al. Ureteral leiomyoma causing hydronephrosis in Type 1 multiple endocrine neoplasia , 2004, Pathology international.
[63] A. Vortmeyer,et al. Meningiomas May Be a Component Tumor of Multiple Endocrine Neoplasia Type 1 , 2004, Clinical Cancer Research.
[64] R. B. van der Luijt,et al. Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? , 2003, European journal of endocrinology.
[65] J. Carpten,et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome , 2002, Nature Genetics.
[66] S. Carty,et al. Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance. , 2002, Surgical oncology.
[67] T. Lairmore,et al. Gastrointestinal Manifestations of Multiple Endocrine Neoplasia Type 2 , 2002, Annals of surgery.
[68] G. Sassolas,et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. , 2002, Journal of Clinical Endocrinology and Metabolism.
[69] B. Ponder,et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. , 2001, The Journal of clinical endocrinology and metabolism.
[70] John P. Bilezikian,et al. CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 , 2001 .
[71] M. Sawicki,et al. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1. , 2001, Molecular endocrinology.
[72] R. Paschke,et al. Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant? , 2001, European journal of endocrinology.
[73] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[74] I. Lubensky,et al. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. , 2000, The Journal of clinical endocrinology and metabolism.
[75] W. Harmsen,et al. Are Patients with Multiple Endocrine Neoplasia Type I Prone to Premature Death? , 2000, World Journal of Surgery.
[76] M. Ichihara,et al. A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations. , 2000, Biochemical and biophysical research communications.
[77] R. Thakker,et al. Multiple endocrine neoplasia type 1. , 1999, Endocrine-related cancer.
[78] C. Eng,et al. Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: implications for treatment , 1999, Gut.
[79] A. Miyauchi,et al. Two Germline Missense Mutations at Codons 804 and 806 of the RET Proto‐oncogene in the Same Allele in a Patient with Multiple Endocrine Neoplasia Type 2B without Codon 918 Mutation , 1999, Japanese journal of cancer research : Gann.
[80] J. Olson,et al. Lethality of Multiple Endocrine Neoplasia Type I , 1998, World Journal of Surgery.
[81] A. Vortmeyer,et al. Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas. , 1998, Journal of the National Cancer Institute.
[82] P. Beck‐Peccoz,et al. Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types , 1997, Clinical endocrinology.
[83] S. Steinberg,et al. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. , 1997, Archives of dermatology.
[84] S. Egawa,et al. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan. , 1997, Japanese journal of clinical oncology.
[85] K. Herfarth,et al. Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. , 1996, Surgery.
[86] C. Larsson,et al. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. , 1996, The Journal of clinical endocrinology and metabolism.
[87] M. Endo,et al. Multiple endocrine neoplasia type 1 associated with spinal ependymoma. , 1996, Internal medicine.
[88] J. Rastad,et al. Adrenal lesion in multiple endocrine neoplasia type 1. , 1995, Surgery.
[89] B. Ponder,et al. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. , 1995, The Journal of clinical endocrinology and metabolism.
[90] S. Chew,et al. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. , 1995, American journal of human genetics.
[91] B. Ponder,et al. Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma , 1995, Genes, chromosomes & cancer.
[92] L. Mulligan,et al. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. , 1994, Human molecular genetics.
[93] Elena S. Di Martino,et al. Identification of the Cys634->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis , 1994, Journal of endocrinological investigation.
[94] L. Bardram,et al. Screening For Multiple Endocrine Neoplasia Type 1 In Patients With Recognized Pituitary Adenoma , 1990, Clinical endocrinology.
[95] C. Larsson,et al. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma , 1988, Nature.
[96] J. Sipple. The association of pheochromocytoma with carcinoma of the thyroid gland , 1961 .
[97] R. Fraser,et al. Multiple Endocrine Adenomas , 1960 .
[98] C. Jackson. Hereditary hyperparathyroidism associated with recurrent pancreatitis. , 1958, Annals of internal medicine.
[99] P. Wermer. Genetic aspects of adenomatosis of endocrine glands. , 1954, The American journal of medicine.
[100] F. Raue,et al. [Multiple endocrine neoplasia]. , 2017, Deutsche medizinische Wochenschrift.
[101] S. Wajner,et al. Advances and controversies in the management of medullary thyroid carcinoma , 2017, Current opinion in oncology.
[102] E. Capoluongo,et al. Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years. , 2016, Cancer genetics.
[103] P. Chanson,et al. Genetic mutations in sporadic pituitary adenomas—what to screen for? , 2015, Nature Reviews Endocrinology.
[104] T. Bacchella,et al. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life. , 2014, The Journal of clinical endocrinology and metabolism.
[105] Douglas B. Evans,et al. Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening , 2012, Annals of Surgical Oncology.
[106] M. Iacobone,et al. Hyperparathyroidism-Jaw Tumor Syndrome , 2020, Definitions.
[107] R. DeLellis. Pathology and genetics of tumours of endocrine organs , 2004 .
[108] G M Lenoir,et al. Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine. , 1997, American journal of human genetics.
[109] C. Eng,et al. Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma [4] , 1997 .
[110] J. Higginson,et al. International Agency for Research on Cancer. , 1968, WHO chronicle.
[111] B. M. Black,et al. Multiple endocrine adenomas; report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved. , 1953, The Journal of clinical endocrinology and metabolism.